Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 29;14(1):23.
doi: 10.1186/s13023-019-1004-x.

Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study

Laura L Tosi  1 , Marianne K Floor  2 , Christina M Dollar  2 , Austin P Gillies  2 ; Members of the Brittle Bone Disease Consortium; Tracy S Hart  3 , David D Cuthbertson  4 , V Reid Sutton  5   6 , Jeffrey P Krischer  4
Collaborators, Affiliations

Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study

Laura L Tosi et al. Orphanet J Rare Dis. .

Abstract

Background: Patient reported outcome (PRO) information is crucial for establishing better patient-provider communication, improving shared decision-making between clinicians and patients, assessing patient responses to therapeutic interventions, and increasing satisfaction with care. We used the Brittle Bones Disease Consortium (BBDC) Contact Registry for People with OI, managed by the Rare Disease Clinical Research Network (RDCRN) to (1) to evaluate the construct validity of the Patient-Reported Outcome Measurement Information System® (PROMIS®) to record important components of the disease experience among individuals with OI; and (2) explore the feasibility of using a registry to recruit individuals with OI to report on health status. Our long-term goal is to enhance communication of health and disease management findings back to the OI community, especially those who do not have access to major OI clinical centers.

Results: We demonstrated the construct validity of PROMIS instruments in OI. Our results confirm that the scores from most domains differ significantly from the general US population: individuals with OI have worse symptom burden and functioning. We found no excessive floor or ceiling effects. Our study demonstrates that the BBDC Contact Registry can be used to recruit participants for online health status surveys. However, there are numerous challenges that must be addressed: lack of self-knowledge of OI type, under-representation of men, limited ethnic diversity, and imperfect questionnaire completion rates.

Conclusion: Our pilot study demonstrated the feasibility of using a contact registry to recruit respondents from the OI community and to obtain analyzable PROMIS data regarding disease experience. Because the results differ from the general population and avoid excessive floor and ceiling effects, PROMIS instruments can be used to assess response to therapeutic interventions in individuals with OI. Future directions will include (1) development and validation of an OI-specific patient-based classification system that aggregates persons with similar clinical characteristics and risks for complications to identify treatment needs; and (2) integrating these PRO tools into routine patient care and research studies.

Keywords: Health-related quality of life (HRQoL); Osteogenesis imperfecta; Patient reported outcomes; Patient-reported outcome measurement information system® (PROMIS®); Pediatric outcomes data collection instrument (PODCI); Rare disease; Registry.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

IRB approval for the pilot project was provided by the University of South Florida, the home institution of the Contact Registry.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Distribution of Patients by Age and Sex
Fig. 2
Fig. 2
Distribution of Patients by Age and OI Type
See this image and copyright information in PMC

References

    1. Augustin G, Jelincic Z, Majerovic M, Stefancic L. Carcinoma of left colon presenting as mechanical obstruction in a patient with osteogenesis imperfecta type III. J Inherit Metab Dis. 2007;30:109–110. doi: 10.1007/s10545-006-0438-1. - DOI - PubMed
    1. Basel D, Steiner RD. Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition. Genet Med. 2009;11:375–385. doi: 10.1097/GIM.0b013e3181a1ff7b. - DOI - PubMed
    1. Bilkay U, Tiftikcioglu YO, Mezili C. Management of nasal deformity in osteogenesis imperfecta. J Craniofac Surg. 2010;21:1465–1467. doi: 10.1097/SCS.0b013e3181ecc55a. - DOI - PubMed
    1. Bonita RE, Cohen IS, Berko BA. Valvular heart disease in osteogenesis imperfecta: presentation of a case and review of the literature. Echocardiography. 2010;27:69–73. doi: 10.1111/j.1540-8175.2009.00973.x. - DOI - PubMed
    1. Byra P, Chillag S, Petit S. Osteogenesis imperfecta and aortic dissection. Am J Med Sci. 2008;336:70–72. doi: 10.1097/MAJ.0b013e318158e981. - DOI - PubMed

Publication types